Generics
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
18 November 2025 - Clinical-stage biopharmaceutical company Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) on Monday announced results from its joint research with Virginia Commonwealth University (VCU) eva...
Ingenus Pharmaceuticals' generic equivalent to Premarin receives US FDA approval
14 November 2025 - US-based based generic pharmaceutical company Ingenus Pharmaceuticals announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for its Conj...
EirGenix signs second global exclusive licensing deal with Sandoz
13 November 2025 - Taiwan-based contract development and manufacturing organisation EirGenix Inc (TWSE:6589) announced on Wednesday that it has signed a second global exclusive licensing agreement wit...
Padagis invests USD36m to expand manufacturing in Minneapolis
29 October 2025 - US-based generic pharmaceuticals company Padagis announced on Tuesday that it is investing more than USD36m to expand its manufacturing operations in Minneapolis, Minnesota.This incl...
Newbury Pharmaceuticals gains Danish approval for generic ivermectin cream
23 October 2025 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Thursday that it has been granted Marketing Authorization for Ivermectin Newbury 10 mg/g cream in ...
BioArctic and Eisai's Leqembi Iqlik (lecanemab-irmb) selected as one of TIME's best innovations of 2025
14 October 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Tuesday that Leqembi Iqlik, a subcutaneous autoinject...